Investing Profile

Mike Moradi

Investor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
3
CompanyStageDateRound SizeTotal Raised
Moat Biotechnology
Series UnknownFeb 2023$7M
$7M
nSight Surgical
SeedNov 2022$1M
$4M
Co-investors: Tommy Martin (Mammoth VC)
Recuro Health
Convertible NoteMar 2022
$62M
Co-investors: Mitchel Laskey (DeepWork Capital), Robert Nelsen (ARCH Venture Partners)